Effects of zibotentan and dapagliflozin on patients with compensated cirrhosis: a randomized double-blind placebo controlled exploratory pilot study

被引:0
作者
Garcia-Pagan, Juan Carlos [1 ]
Lotte Gluud, Lise [2 ]
Mandorfer, Mattias [3 ]
Schattenberg, Jorn M. [4 ]
De Gottardi, Andrea [5 ]
Berzigotti, Annalisa [6 ]
Ignacio Fortea, Jose [7 ]
Albillos, Agustin [8 ]
Alvarado-Tapias, Edilmar [9 ]
Berning, Marco [10 ]
Petryszyn, Pawel [11 ]
Lin, Min [12 ]
Ambery, Philip [13 ]
Bosch, Jaime [14 ]
Oscarsson, Jan [13 ]
Rockey, Don [15 ]
机构
[1] Hosp Clin Barcelona, Barcelona, Spain
[2] Univ Copenhagen, Hvidovre Hosp, Hvidovre, Denmark
[3] Med Univ Vienna, Vienna, Austria
[4] Saarland Univ, Med Ctr, Homburg, Germany
[5] Univ Svizzera Italiana, Lugano, Switzerland
[6] Univ Bern, Univ Hosp Bern, Bern, Switzerland
[7] Univ Marques Valdecilla, Dept Hosp, Santander, Spain
[8] Hosp Univ Ramon & Cajal, Madrid, Spain
[9] Autonomus Univ Barcelona, Barcelona, Spain
[10] Univ Hosp Dresden, Dresden, Germany
[11] AstraZeneca, Warsaw, Poland
[12] AstraZeneca, Gaithersburg, MD USA
[13] AstraZeneca, Gothenburg, Sweden
[14] Bern Univ Hosp, Bern, Switzerland
[15] Med Univ South Carolina, Charleston, SC USA
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
SAT-069
引用
收藏
页码:S238 / S239
页数:2
相关论文
共 50 条
  • [41] Effects of probiotic therapy in critically ill patients: a randomized, double-blind, placebo-controlled study
    Alberda, C
    Gramlich, L
    Field, C
    McCargar, L
    Meddings, J
    Madsen, K
    [J]. GASTROENTEROLOGY, 2005, 128 (04) : A281 - A282
  • [42] Antiplatelet effects of citalopram in patients with ischaemic stroke: A randomized, placebo-controlled, double-blind study
    Kraglund, Kristian Lundsgaard
    Mortensen, Janne Kaergaard
    Johnsen, Soren Paaske
    Andersen, Grethe
    Grove, Erik Lerkevang
    [J]. SCIENTIFIC REPORTS, 2019, 9 (1)
  • [43] Exploratory Study of Safety and Efficacy of Ocrelizumab in Autoimmune Encephalitis: A Randomized, Double-Blind, Placebo Controlled Trial
    Blackburn, Kyle M.
    Denney, David A.
    Hopkins, Steven C.
    Vernino, Steven A.
    [J]. ANNALS OF NEUROLOGY, 2021, 90 : S24 - S24
  • [44] Effects of Amantadine on Tardive Dyskinesia: A Randomized, Double-Blind, Placebo-Controlled Study
    Pappa, Sofia
    Tsouli, Sofia
    Apostolou, George
    Mavreas, Venetsanos
    Konitsiotis, Spiridon
    [J]. CLINICAL NEUROPHARMACOLOGY, 2010, 33 (06) : 271 - 275
  • [45] Immunomodulatory Effects of ResistAid™: A Randomized, Double-Blind, Placebo-Controlled, Multidose Study
    Udani, Jay K.
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF NUTRITION, 2013, 32 (05) : 331 - 338
  • [46] Effects of Febuxostat in Early Gout A Randomized, Double-Blind, Placebo-Controlled Study
    Dalbeth, Nicola
    Saag, Kenneth G.
    Palmer, William E.
    Choi, Hyon K.
    Hunt, Barbara
    MacDonald, Patricia A.
    Thienel, Ulrich
    Gunawardhana, Lhanoo
    [J]. ARTHRITIS & RHEUMATOLOGY, 2017, 69 (12) : 2386 - 2395
  • [47] Effects of levetiracetam on tardive dyskinesia: A randomized, double-blind, placebo-controlled study
    Woods, Scott W.
    Saksa, John R.
    Baker, C. Bruce
    Cohen, Shuki J.
    Tek, Cenk
    [J]. JOURNAL OF CLINICAL PSYCHIATRY, 2008, 69 (04) : 546 - 554
  • [48] Effects of the PREMEN-CALM® in the Management of the Premenstrual Syndrome: A Randomized, Double-Blind, Placebo-Controlled Pilot Study
    Herrera, Andrea
    Al Adib, Miriam
    Rodriguez, Ana Beatriz
    Carrasco, Cristina
    [J]. JOURNAL OF DIETARY SUPPLEMENTS, 2024, 21 (04) : 495 - 511
  • [49] Effects of intratympanic injection of latanoprost in Meniere's disease: a randomized, placebo-controlled, double-blind, pilot study
    Rask-Andersen, H
    Friberg, U
    Johansson, M
    Stiernschantz, J
    [J]. OTOLARYNGOLOGY-HEAD AND NECK SURGERY, 2005, 133 (03) : 441 - 443
  • [50] A randomized, double-blind, placebo-controlled study of olanzapine in patients with bipolar depression
    Tohen, M.
    McDonnell, D. P.
    Case, M.
    Kanba, S.
    Ha, K.
    Fang, Y.
    Katagiri, H.
    Gomez, J. C.
    [J]. BIPOLAR DISORDERS, 2011, 13 : 100 - 100